Acorah Software Products - Accounts Production 16.5.460 false true false true No description of principal activity 2 March 2024 31 March 2025 31 March 2025 15535656 Mr Manhal Al-Gurgia Dr Alya Al-Obaidi iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15535656 2024-03-01 15535656 2025-03-31 15535656 2024-03-02 2025-03-31 15535656 frs-core:CurrentFinancialInstruments 2025-03-31 15535656 frs-bus:PrivateLimitedCompanyLtd 2024-03-02 2025-03-31 15535656 frs-bus:FilletedAccounts 2024-03-02 2025-03-31 15535656 frs-bus:Micro-entities 2024-03-02 2025-03-31 15535656 frs-bus:AuditExempt-NoAccountantsReport 2024-03-02 2025-03-31 15535656 frs-bus:Director1 2024-03-02 2025-03-31 15535656 frs-bus:Director2 2024-03-02 2025-03-31
Registered number: 15535656
Clear Vision Medical Ltd
Unaudited Financial Statements
For the Period 2 March 2024 to 31 March 2025
Accountology Ltd
Balance Sheet
Registered number: 15535656
31 March 2025
£
Fixed assets 2,820
Current assets 7,061
Creditors: Amounts Falling Due Within One Year (1,472 )
NET CURRENT ASSETS 5,589
TOTAL ASSETS LESS CURRENT LIABILITIES 8,409
Accruals and deferred income (1,010 )
NET ASSETS 7,399
CAPITAL AND RESERVES 7,399

Notes

1. General Information
Clear Vision Medical Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15535656 . The registered office is 32 Kenilworth Road, Sale, M33 5FB.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Alya Al-Obaidi
Director
23/08/2025